Comment on Merck Drug Shows Improved Odds for Melanoma Patients

Merck Drug Shows Improved Odds for Melanoma Patients

Merck’s new cancer drug Keytruda improved the survival odds of patients with the skin cancer melanoma compared with Bristol-Myers Squibb’s Yervoy, in the first head-to-head study of a new wave of drugs that harness the body’s immune system to destroy tumors

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News